Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib
Clinical trial NCT06754761 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06754761
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-17
- Primary completion
- 2025-08-08
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.